Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
J Am Coll Cardiol 2022 Jul 12;80(2)95-108, MY Desai, A Owens, JB Geske, K Wolski, SS Naidu, NG Smedira, PC Cremer, H Schaff, E McErlean, C Sewell, W Li, L Sterling, K Lampl, JM Edelberg, AJ Sehnert, SE NissenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.